25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IPD (Impedimed) Stock Analysis
Buy, Hold or Sell?

Let's analyze Impedimed together

I guess you are interested in Impedimed Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Impedimed’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Impedimed’s Price Targets

I'm going to help you getting a better view of Impedimed Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Impedimed Ltd

I send you an email if I find something interesting about Impedimed Ltd.

1. Quick Overview

1.1. Quick analysis of Impedimed (30 sec.)










1.2. What can you expect buying and holding a share of Impedimed? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.04
Return On Investment
-110.3%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.034 - A$0.041
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Impedimed (5 min.)




Live pricePrice per Share (EOD)
A$0.04
Intrinsic Value Per Share
A$-0.11 - A$-0.09
Total Value Per Share
A$-0.09 - A$-0.07

2.2. Growth of Impedimed (5 min.)




Is Impedimed growing?

Current yearPrevious yearGrowGrow %
How rich?$26.7m$40m-$13.2m-49.4%

How much money is Impedimed making?

Current yearPrevious yearGrowGrow %
Making money-$13m-$13.4m$480.5k3.7%
Net Profit Margin-191.8%-180.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Impedimed (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#186 / 297

Most Revenue
#200 / 297

Most Profit
#253 / 297

Most Efficient
#241 / 297
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Impedimed?

Welcome investor! Impedimed's management wants to use your money to grow the business. In return you get a share of Impedimed.

First you should know what it really means to hold a share of Impedimed. And how you can make/lose money.

Speculation

The Price per Share of Impedimed is A$0.036. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Impedimed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Impedimed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Impedimed.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-17.8%-0.01-17.8%-0.01-18.5%-0.01-18.1%-0.01-18.4%-0.01-20.0%
Usd Book Value Change Per Share-0.01-18.1%-0.01-18.1%0.008.9%0.004.6%0.004.5%0.002.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.4%0.000.2%0.000.3%0.000.2%
Usd Total Gains Per Share-0.01-18.1%-0.01-18.1%0.009.2%0.004.8%0.004.8%0.002.6%
Usd Price Per Share0.05-0.05-0.12-0.07-0.06-0.23-
Price to Earnings Ratio-7.38--7.38--17.78--10.46--9.51--33.43-
Price-to-Total Gains Ratio-7.25--7.25-35.57-11.03--24.89--10.85-
Price to Book Ratio3.58-3.58-5.99-4.00-4.99-16.09-
Price-to-Total Gains Ratio-7.25--7.25-35.57-11.03--24.89--10.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0236664
Number of shares42253
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (42253 shares)-275.8773.29
Gains per Year (42253 shares)-1,103.47293.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1103-111320274283
20-2207-221639547576
30-3310-331959821869
40-4414-44227910941162
50-5517-55259813681455
60-6621-662811816411748
70-7724-773113719152041
80-8828-883415721882334
90-9931-993717724622627
100-11035-1104019627352920

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.017.02.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%8.011.00.042.1%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%4.00.06.040.0%6.00.013.031.6%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%8.011.00.042.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Impedimed Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.010-0.0100%0.005-305%0.003-497%0.002-503%0.001-840%
Book Value Per Share--0.0200.0200%0.030-33%0.025-20%0.020-1%0.022-7%
Current Ratio--6.3266.3260%8.884-29%7.217-12%5.957+6%7.883-20%
Debt To Asset Ratio--0.1330.1330%0.114+16%0.126+6%0.161-17%0.147-10%
Debt To Equity Ratio--0.1530.1530%0.129+19%0.144+6%0.196-22%0.182-16%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%0.000-100%
Enterprise Value--164368283.456164368283.4560%402801208.640-59%241307128.341-32%217492444.608-24%750808886.964-78%
Eps---0.010-0.0100%-0.010+4%-0.010+1%-0.010+3%-0.011+12%
Ev To Ebitda Ratio---7.454-7.4540%-19.656+164%-11.838+59%-10.426+40%-33.597+351%
Ev To Sales Ratio--15.92915.9290%35.508-55%22.091-28%23.445-32%140.985-89%
Free Cash Flow Per Share---0.010-0.0100%-0.012+15%-0.011+5%-0.010-1%-0.010-2%
Free Cash Flow To Equity Per Share---0.011-0.0110%0.002-657%0.000-4384%0.001-1069%0.001-1925%
Gross Profit Margin--1.0261.0260%1.022+0%1.0270%1.0290%1.039-1%
Intrinsic Value_10Y_max---0.092----------
Intrinsic Value_10Y_min---0.111----------
Intrinsic Value_1Y_max---0.010----------
Intrinsic Value_1Y_min---0.011----------
Intrinsic Value_3Y_max---0.029----------
Intrinsic Value_3Y_min---0.033----------
Intrinsic Value_5Y_max---0.048----------
Intrinsic Value_5Y_min---0.056----------
Market Cap72989641.728-100%145979283.456145979283.4560%364948208.640-60%211534795.008-31%194639044.608-25%720792986.964-80%
Net Profit Margin---1.918-1.9180%-1.809-6%-1.869-3%-2.359+23%-3.810+99%
Operating Margin---2.355-2.3550%-2.024-14%-2.135-9%-2.703+15%-4.228+80%
Operating Ratio--2.8452.8450%3.014-6%2.956-4%3.610-21%4.965-43%
Pb Ratio1.791-100%3.5833.5830%5.995-40%4.000-10%4.988-28%16.093-78%
Pe Ratio-3.688+50%-7.376-7.3760%-17.784+141%-10.461+42%-9.509+29%-33.427+353%
Price Per Share0.036-100%0.0720.0720%0.180-60%0.104-31%0.096-25%0.356-80%
Price To Free Cash Flow Ratio-3.493+50%-6.987-6.9870%-15.148+117%-9.352+34%-9.497+36%-39.850+470%
Price To Total Gains Ratio-3.625+50%-7.250-7.2500%35.570-120%11.032-166%-24.889+243%-10.845+50%
Quick Ratio--5.7605.7600%8.268-30%6.677-14%5.393+7%7.199-20%
Return On Assets---0.421-0.4210%-0.299-29%-0.353-16%-0.462+10%-0.513+22%
Return On Equity---0.486-0.4860%-0.337-31%-0.404-17%-0.561+15%-0.628+29%
Total Gains Per Share---0.010-0.0100%0.005-296%0.003-477%0.003-476%0.001-794%
Usd Book Value--26784448.20026784448.2000%40021854.600-33%33454209.467-20%27024530.680-1%28663823.320-7%
Usd Book Value Change Per Share---0.007-0.0070%0.003-305%0.002-497%0.002-503%0.001-840%
Usd Book Value Per Share--0.0130.0130%0.020-33%0.017-20%0.013-1%0.014-7%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%0.000-100%
Usd Enterprise Value--108055709.544108055709.5440%264801514.560-59%158635306.172-32%142979533.085-24%493581762.290-78%
Usd Eps---0.006-0.0060%-0.007+4%-0.007+1%-0.007+3%-0.007+12%
Usd Free Cash Flow---13735715.600-13735715.6000%-15838080.800+15%-14434531.800+5%-13537838.200-1%-13510950.540-2%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.008+15%-0.007+5%-0.007-1%-0.007-2%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%0.001-657%0.000-4384%0.001-1069%0.000-1925%
Usd Market Cap47983390.472-100%95966780.94495966780.9440%239916952.360-60%139062974.238-31%127955707.925-25%473849309.630-80%
Usd Price Per Share0.024-100%0.0470.0470%0.118-60%0.069-31%0.063-25%0.234-80%
Usd Profit---13009946.000-13009946.0000%-13490505.400+4%-13188539.667+1%-13446196.640+3%-14585076.400+12%
Usd Revenue--6783710.6006783710.6000%7457545.600-9%7062448.200-4%6097910.920+11%4618497.960+47%
Usd Total Gains Per Share---0.007-0.0070%0.003-296%0.002-477%0.002-476%0.001-794%
 EOD+3 -5MRQTTM+0 -0YOY+11 -293Y+10 -305Y+17 -2310Y+15 -25

3.3 Fundamental Score

Let's check the fundamental score of Impedimed Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.688
Price to Book Ratio (EOD)Between0-11.791
Net Profit Margin (MRQ)Greater than0-1.918
Operating Margin (MRQ)Greater than0-2.355
Quick Ratio (MRQ)Greater than15.760
Current Ratio (MRQ)Greater than16.326
Debt to Asset Ratio (MRQ)Less than10.133
Debt to Equity Ratio (MRQ)Less than10.153
Return on Equity (MRQ)Greater than0.15-0.486
Return on Assets (MRQ)Greater than0.05-0.421
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Impedimed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.388
Ma 20Greater thanMa 500.032
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.038
OpenGreater thanClose0.037
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Impedimed Ltd

ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.

Fundamental data was last updated by Penke on 2025-06-30 05:23:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Impedimed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -191.8%Β means thatΒ $-1.92 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Impedimed Ltd:

  • The MRQ is -191.8%. The company is making a huge loss. -2
  • The TTM is -191.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-191.8%TTM-191.8%0.0%
TTM-191.8%YOY-180.9%-10.9%
TTM-191.8%5Y-235.9%+44.1%
5Y-235.9%10Y-381.0%+145.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-191.8%-7.5%-184.3%
TTM-191.8%-10.2%-181.6%
YOY-180.9%-10.9%-170.0%
3Y-186.9%-13.1%-173.8%
5Y-235.9%-10.3%-225.6%
10Y-381.0%-9.3%-371.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Impedimed is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • -42.1% Return on Assets means thatΒ Impedimed generatedΒ $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Impedimed Ltd:

  • The MRQ is -42.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.1%TTM-42.1%0.0%
TTM-42.1%YOY-29.9%-12.3%
TTM-42.1%5Y-46.2%+4.1%
5Y-46.2%10Y-51.3%+5.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.1%-2.1%-40.0%
TTM-42.1%-2.4%-39.7%
YOY-29.9%-3.1%-26.8%
3Y-35.3%-2.6%-32.7%
5Y-46.2%-2.6%-43.6%
10Y-51.3%-2.3%-49.0%
4.3.1.3. Return on Equity

Shows how efficient Impedimed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • -48.6% Return on Equity means Impedimed generated $-0.49Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Impedimed Ltd:

  • The MRQ is -48.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -48.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-48.6%TTM-48.6%0.0%
TTM-48.6%YOY-33.7%-14.9%
TTM-48.6%5Y-56.1%+7.5%
5Y-56.1%10Y-62.8%+6.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-48.6%-1.9%-46.7%
TTM-48.6%-2.6%-46.0%
YOY-33.7%-2.6%-31.1%
3Y-40.4%-3.7%-36.7%
5Y-56.1%-4.1%-52.0%
10Y-62.8%-6.1%-56.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Impedimed Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Impedimed is operatingΒ .

  • Measures how much profit Impedimed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • An Operating Margin of -235.5%Β means the company generated $-2.36 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Impedimed Ltd:

  • The MRQ is -235.5%. The company is operating very inefficient. -2
  • The TTM is -235.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-235.5%TTM-235.5%0.0%
TTM-235.5%YOY-202.4%-33.1%
TTM-235.5%5Y-270.3%+34.8%
5Y-270.3%10Y-422.8%+152.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-235.5%-11.2%-224.3%
TTM-235.5%-13.6%-221.9%
YOY-202.4%-9.8%-192.6%
3Y-213.5%-9.5%-204.0%
5Y-270.3%-9.5%-260.8%
10Y-422.8%-9.4%-413.4%
4.3.2.2. Operating Ratio

Measures how efficient Impedimed is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 2.84 means that the operating costs are $2.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Impedimed Ltd:

  • The MRQ is 2.845. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.845. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.845TTM2.8450.000
TTM2.845YOY3.014-0.169
TTM2.8455Y3.610-0.765
5Y3.61010Y4.965-1.355
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8451.390+1.455
TTM2.8451.368+1.477
YOY3.0141.275+1.739
3Y2.9561.337+1.619
5Y3.6101.349+2.261
10Y4.9651.321+3.644
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Impedimed Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Impedimed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 6.33Β means the company has $6.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Impedimed Ltd:

  • The MRQ is 6.326. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.326. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.326TTM6.3260.000
TTM6.326YOY8.884-2.558
TTM6.3265Y5.957+0.368
5Y5.95710Y7.883-1.925
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3262.510+3.816
TTM6.3262.610+3.716
YOY8.8842.651+6.233
3Y7.2172.949+4.268
5Y5.9573.539+2.418
10Y7.8833.302+4.581
4.4.3.2. Quick Ratio

Measures if Impedimed is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • A Quick Ratio of 5.76Β means the company can pay off $5.76 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Impedimed Ltd:

  • The MRQ is 5.760. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.760. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.760TTM5.7600.000
TTM5.760YOY8.268-2.508
TTM5.7605Y5.393+0.367
5Y5.39310Y7.199-1.806
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7601.071+4.689
TTM5.7601.398+4.362
YOY8.2681.652+6.616
3Y6.6771.816+4.861
5Y5.3932.142+3.251
10Y7.1992.350+4.849
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Impedimed Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ImpedimedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Impedimed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.13Β means that Impedimed assets areΒ financed with 13.3% credit (debt) and the remaining percentage (100% - 13.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Impedimed Ltd:

  • The MRQ is 0.133. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.133. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.133TTM0.1330.000
TTM0.133YOY0.114+0.019
TTM0.1335Y0.161-0.028
5Y0.16110Y0.147+0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1330.400-0.267
TTM0.1330.410-0.277
YOY0.1140.391-0.277
3Y0.1260.388-0.262
5Y0.1610.414-0.253
10Y0.1470.455-0.308
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Impedimed is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 15.3% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Impedimed Ltd:

  • The MRQ is 0.153. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.153. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.153TTM0.1530.000
TTM0.153YOY0.129+0.024
TTM0.1535Y0.196-0.043
5Y0.19610Y0.182+0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1530.554-0.401
TTM0.1530.636-0.483
YOY0.1290.589-0.460
3Y0.1440.631-0.487
5Y0.1960.647-0.451
10Y0.1820.754-0.572
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Impedimed generates.

  • Above 15 is considered overpriced butΒ always compareΒ Impedimed to theΒ Medical Devices industry mean.
  • A PE ratio of -7.38 means the investor is paying $-7.38Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Impedimed Ltd:

  • The EOD is -3.688. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.376. Based on the earnings, the company is expensive. -2
  • The TTM is -7.376. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.688MRQ-7.376+3.688
MRQ-7.376TTM-7.3760.000
TTM-7.376YOY-17.784+10.408
TTM-7.3765Y-9.509+2.133
5Y-9.50910Y-33.427+23.918
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.688-1.120-2.568
MRQ-7.376-1.449-5.927
TTM-7.376-1.183-6.193
YOY-17.784-1.829-15.955
3Y-10.461-1.326-9.135
5Y-9.509-1.482-8.027
10Y-33.427-1.435-31.992
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Impedimed Ltd:

  • The EOD is -3.493. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.987. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.987. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.493MRQ-6.987+3.493
MRQ-6.987TTM-6.9870.000
TTM-6.987YOY-15.148+8.161
TTM-6.9875Y-9.497+2.510
5Y-9.49710Y-39.850+30.353
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.493-2.551-0.942
MRQ-6.987-3.183-3.804
TTM-6.987-1.465-5.522
YOY-15.148-3.394-11.754
3Y-9.352-2.788-6.564
5Y-9.497-2.902-6.595
10Y-39.850-3.379-36.471
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Impedimed is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 3.58 means the investor is paying $3.58Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Impedimed Ltd:

  • The EOD is 1.791. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.583. Based on the equity, the company is fair priced.
  • The TTM is 3.583. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.791MRQ3.583-1.791
MRQ3.583TTM3.5830.000
TTM3.583YOY5.995-2.412
TTM3.5835Y4.988-1.405
5Y4.98810Y16.093-11.106
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.7911.971-0.180
MRQ3.5831.993+1.590
TTM3.5832.230+1.353
YOY5.9952.677+3.318
3Y4.0002.716+1.284
5Y4.9883.855+1.133
10Y16.0934.251+11.842
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Impedimed Ltd.

4.8.2. Funds holding Impedimed Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31DFA Asia Pacific Small Company Series0.029999999-417437--
Total 0.029999999041743700.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -7,614-941-8,555-3,304-11,859-4,942-16,80130,11013,309
Gross Profit  -12,888686-12,202-1,148-13,350-304-13,65422,6599,005



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets46,986
Total Liabilities6,243
Total Stockholder Equity40,743
 As reported
Total Liabilities 6,243
Total Stockholder Equity+ 40,743
Total Assets = 46,986

Assets

Total Assets46,986
Total Current Assets29,458
Long-term Assets17,528
Total Current Assets
Cash And Cash Equivalents 24,632
Net Receivables 2,194
Inventory 759
Other Current Assets 1,873
Total Current Assets  (as reported)29,458
Total Current Assets  (calculated)29,458
+/-0
Long-term Assets
Property Plant Equipment 1,448
Goodwill 2,717
Long Term Investments 54
Intangible Assets 13,309
Long-term Assets  (as reported)17,528
Long-term Assets  (calculated)17,528
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,657
Long-term Liabilities1,586
Total Stockholder Equity40,743
Total Current Liabilities
Short-term Debt 333
Accounts payable 1,096
Other Current Liabilities 3,228
Total Current Liabilities  (as reported)4,657
Total Current Liabilities  (calculated)4,657
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt810
Long-term Liabilities Other 695
Long-term Liabilities  (as reported)1,586
Long-term Liabilities  (calculated)1,505
+/- 81
Total Stockholder Equity
Common Stock336,147
Retained Earnings -330,952
Accumulated Other Comprehensive Income 35,548
Total Stockholder Equity (as reported)40,743
Total Stockholder Equity (calculated)40,743
+/-0
Other
Capital Stock336,147
Cash and Short Term Investments 24,632
Common Stock Shares Outstanding 2,021,741
Current Deferred Revenue1,494
Liabilities and Stockholders Equity 46,986
Net Debt -23,489
Net Invested Capital 40,743
Net Working Capital 24,801
Property Plant and Equipment Gross 5,662
Short Long Term Debt Total 1,143



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
> Total Assets 
4,630
21,789
14,515
13,098
24,910
22,805
19,614
11,864
14,958
37,917
90,570
64,343
41,569
22,581
33,064
34,205
58,699
68,736
46,986
46,98668,73658,69934,20533,06422,58141,56964,34390,57037,91714,95811,86419,61422,80524,91013,09814,51521,7894,630
   > Total Current Assets 
0
18,556
10,751
8,479
21,194
20,214
17,267
9,433
12,740
35,118
87,649
61,255
37,602
16,973
25,450
25,650
46,660
51,935
29,458
29,45851,93546,66025,65025,45016,97337,60261,25587,64935,11812,7409,43317,26720,21421,1948,47910,75118,5560
       Cash And Cash Equivalents 
0
16,266
8,485
6,634
18,789
17,930
14,545
7,316
10,812
32,582
82,254
54,884
31,345
11,330
19,663
19,681
40,730
45,710
24,632
24,63245,71040,73019,68119,66311,33031,34554,88482,25432,58210,8127,31614,54517,93018,7896,6348,48516,2660
       Short-term Investments 
0
148
31
0
0
31
31
0
0
0
0
0
0
0
0
0
0
0
0
000000000000313100311480
       Net Receivables 
786
979
866
744
773
673
769
414
435
619
940
1,227
1,065
1,245
1,656
2,775
2,748
2,625
2,194
2,1942,6252,7482,7751,6561,2451,0651,227940619435414769673773744866979786
       Other Current Assets 
405
329
163
152
257
334
297
373
361
279
3,077
3,679
3,381
3,277
3,267
2,822
2,256
2,790
1,873
1,8732,7902,2562,8223,2673,2773,3813,6793,077279361373297334257152163329405
   > Long-term Assets 
0
3,233
3,764
4,619
3,716
2,591
2,347
2,368
2,168
2,706
2,873
3,088
3,967
5,608
7,614
8,555
12,039
16,801
17,528
17,52816,80112,0398,5557,6145,6083,9673,0882,8732,7062,1682,3682,3472,5913,7164,6193,7643,2330
       Property Plant Equipment 
169
248
396
665
539
425
404
334
203
298
396
518
368
188
1,015
1,030
418
1,951
1,448
1,4481,9514181,0301,015188368518396298203334404425539665396248169
       Goodwill 
1,897
0
2,040
2,252
2,117
1,711
1,784
1,985
1,924
2,368
2,436
2,358
2,449
2,584
2,636
2,415
2,630
2,730
2,717
2,7172,7302,6302,4152,6362,5842,4492,3582,4362,3681,9241,9851,7841,7112,1172,2522,04001,897
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
48
158
95
45
77
73
75
78
54
54787573774595158480000000000
       Intangible Assets 
2,391
2,891
1,286
1,550
920
367
68
49
41
40
41
54
1,055
2,791
6,522
7,452
11,366
14,772
13,309
13,30914,77211,3667,4526,5222,7911,0555441404149683679201,5501,2862,8912,391
       Long-term Assets Other 
0
94
0
124
0
0
0
-2,368
-2,168
-2,706
-48
-3,088
-3,967
-5,608
-7,614
-8,555
-11,859
-16,801
13,309
13,309-16,801-11,859-8,555-7,614-5,608-3,967-3,088-48-2,706-2,168-2,3680001240940
> Total Liabilities 
9,309
2,385
2,215
3,031
2,680
2,122
2,304
1,270
1,426
3,080
5,316
5,546
5,765
6,796
5,703
8,691
7,655
7,857
6,243
6,2437,8577,6558,6915,7036,7965,7655,5465,3163,0801,4261,2702,3042,1222,6803,0312,2152,3859,309
   > Total Current Liabilities 
9,125
2,272
1,869
2,595
2,529
1,975
2,206
1,186
1,336
2,976
5,201
5,469
5,663
6,661
5,109
8,134
7,242
5,846
4,657
4,6575,8467,2428,1345,1096,6615,6635,4695,2012,9761,3361,1862,2061,9752,5292,5951,8692,2729,125
       Short-term Debt 
0
711
64
0
0
0
0
0
0
0
73
58
230
520
364
-562
-758
141
333
333141-758-56236452023058730000000647110
       Accounts payable 
753
1,239
723
962
790
744
1,034
303
350
1,131
1,828
2,142
1,805
2,086
1,913
1,296
2,638
1,355
1,096
1,0961,3552,6381,2961,9132,0861,8052,1421,8281,1313503031,0347447909627231,239753
       Other Current Liabilities 
7,318
322
1,082
1,633
1,739
1,231
1,172
883
986
1,845
3,300
3,269
3,858
4,575
2,254
5,646
3,506
3,160
3,228
3,2283,1603,5065,6462,2544,5753,8583,2693,3001,8459868831,1721,2311,7391,6331,0823227,318
   > Long-term Liabilities 
0
113
346
436
151
147
98
84
90
104
115
77
102
135
594
557
413
2,011
1,586
1,5862,011413557594135102771151049084981471514363461130
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
507
159
0
1,147
0
01,147015950700000000000000
       Capital Lease Obligations Min Short Term Debt
0
-711
-64
0
0
0
0
0
0
0
-73
-58
-230
-520
507
1,036
928
1,306
810
8101,3069281,036507-520-230-58-730000000-64-7110
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
218
360
422
695
695422360218000000000000000
> Total Stockholder Equity
0
19,404
12,300
10,067
22,230
20,683
17,310
10,594
13,532
34,837
85,254
58,797
35,804
15,785
27,361
25,514
51,044
60,879
40,743
40,74360,87951,04425,51427,36115,78535,80458,79785,25434,83713,53210,59417,31020,68322,23010,06712,30019,4040
   Retained Earnings -330,952-311,162-290,641-270,767-250,061-228,717-204,594-177,222-149,651-123,671-108,874-100,939-92,475-80,133-65,311-53,909-39,881-31,8090
   Accumulated Other Comprehensive Income 
0
1,187
1,372
2,491
2,982
2,812
3,683
5,432
5,813
11,159
16,098
16,526
20,652
24,775
26,859
29,013
34,127
35,954
35,548
35,54835,95434,12729,01326,85924,77520,65216,52616,09811,1595,8135,4323,6832,8122,9822,4911,3721,1870
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue10,319
Cost of Revenue-1,314
Gross Profit9,0059,005
 
Operating Income (+$)
Gross Profit9,005
Operating Expense-28,041
Operating Income-19,036-19,036
 
Operating Expense (+$)
Research Development221
Selling General Administrative22,095
Selling And Marketing Expenses524
Operating Expense28,04122,840
 
Net Interest Income (+$)
Interest Income1,559
Interest Expense-93
Other Finance Cost-0
Net Interest Income1,466
 
Pretax Income (+$)
Operating Income-19,036
Net Interest Income1,466
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-20,725-17,347
EBIT - interestExpense = -24,397
-20,725
-19,697
Interest Expense93
Earnings Before Interest and Taxes (EBIT)-24,304-20,632
Earnings Before Interest and Taxes (EBITDA)-22,051
 
After tax Income (+$)
Income Before Tax-20,725
Tax Provision-33
Net Income From Continuing Ops-19,790-20,758
Net Income-19,790
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses29,355
Total Other Income/Expenses Net-1,689-1,466
 

Technical Analysis of Impedimed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Impedimed. The general trend of Impedimed is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Impedimed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Impedimed Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Impedimed Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0405 < 0.041 < 0.041.

The bearish price targets are: 0.034 > 0.034 > 0.034.

Know someone who trades $IPD? Share this with them.πŸ‘‡

Impedimed Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Impedimed Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Impedimed Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Impedimed Ltd. The current macd is 0.00120793.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Impedimed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Impedimed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Impedimed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Impedimed Ltd Daily Moving Average Convergence/Divergence (MACD) ChartImpedimed Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Impedimed Ltd. The current adx is 24.79.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Impedimed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Impedimed Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Impedimed Ltd. The current sar is 0.02984388.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Impedimed Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Impedimed Ltd. The current rsi is 56.39. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Impedimed Ltd Daily Relative Strength Index (RSI) ChartImpedimed Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Impedimed Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Impedimed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Impedimed Ltd Daily Stochastic Oscillator ChartImpedimed Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Impedimed Ltd. The current cci is 107.94.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Impedimed Ltd Daily Commodity Channel Index (CCI) ChartImpedimed Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Impedimed Ltd. The current cmo is 15.42.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Impedimed Ltd Daily Chande Momentum Oscillator (CMO) ChartImpedimed Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Impedimed Ltd. The current willr is -23.07692308.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Impedimed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Impedimed Ltd Daily Williams %R ChartImpedimed Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Impedimed Ltd.

Impedimed Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Impedimed Ltd. The current atr is 0.00245974.

Impedimed Ltd Daily Average True Range (ATR) ChartImpedimed Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Impedimed Ltd. The current obv is -167,619,099.

Impedimed Ltd Daily On-Balance Volume (OBV) ChartImpedimed Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Impedimed Ltd. The current mfi is 45.96.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Impedimed Ltd Daily Money Flow Index (MFI) ChartImpedimed Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Impedimed Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Impedimed Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Impedimed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.388
Ma 20Greater thanMa 500.032
Ma 50Greater thanMa 1000.033
Ma 100Greater thanMa 2000.038
OpenGreater thanClose0.037
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Impedimed with someone you think should read this too:
  • Are you bullish or bearish on Impedimed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Impedimed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Impedimed Ltd

I send you an email if I find something interesting about Impedimed Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Impedimed Ltd.

Receive notifications about Impedimed Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.